SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Regulus Therapeutics Inc. - RGLS

Group 1 - Monteverde & Associates PC has recovered millions for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report [1] - The firm is investigating Regulus Therapeutics Inc. regarding its proposed merger with Novartis AG, which includes an initial payment of $7.00 per share and a non-tradeable CVR of $7.00 per share contingent on regulatory approval [1] Group 2 - The firm operates from the Empire State Building in New York City and has a successful track record in trial and appellate courts, including the U.S. Supreme Court [2] - Monteverde & Associates PC emphasizes that no company, director, or officer is above the law, and offers free information to shareholders concerned about their investments [3]